Predicting hepatitis C treatment success

Levels of interferon-stimulated genes in the liver and blood could help predict if a patient with hepatitis C will respond to conventional therapy, researchers at Kanazawa University suggest.

A combined therapy using interferons and ribavirin is often used to treat C, but around half of patients are unresponsive and suffer relapse. Previous research has shown that variations in a gene called interleukin 28B (IL28B) render a patient either sensitive to treatment or completely resistant to it. However, the mechanisms relating the IL28B gene to the treatment are not well understood.

Now, Shuichi Kaneko and colleagues at Kanazawa University have discovered that, in therapy-resistant patients, interferon-stimulated gene (ISG) expression is up-regulated in the liver but down-regulated in the blood - a significantly different pattern of ISG expression to therapy-responsive patients.

The team analyzed liver and blood samples from hepatitis C patients taken before treatment, and found that fewer immune cells reached the livers of patients with the therapy-resistant genotype. The team believe this lack of may induce higher levels of other inflammatory proteins, such as WNT5A. Higher WNT5A levels in the therapy-resistant both enhanced the expression of ISGs in the liver and increased hepatitis C viral replication. The researchers hope that further research will clarify these mechanisms with regard to treatment response.

In the meantime, measuring ISG expression patterns in blood and samples could provide a useful way of predicting a patient's response to interferon / ribavirin therapy.

More information: Honda, M., Shirasaki, T., Shimakami, T., Sakai, A., Horii, R., Arai, K., Yamashita, T., Sakai, Y., Yamashita, T., Okada, H., Murai, K., Nakamura, M., Mizukoshi, E. and Kaneko, S. (2014), "Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes." Hepatology, 59: 828–838. doi: 10.1002/hep.26788

add to favorites email to friend print save as pdf

Related Stories

New combination therapy for hepatitis C

May 05, 2014

A new combination therapy allows chronic hepatitis C to be treated in a manner that is less aggressive yet equally efficient. This is the result of a current study, led by primary author Peter Ferenci from ...

Good news for some hard-to-treat hepatitis C patients

Jun 16, 2009

In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to ...

Recommended for you

Cremation fears leave empty Ebola beds in Liberia

13 minutes ago

Even as Liberians fall ill and die of Ebola, more than half the beds in treatment centers in the capital remain empty, an unintended consequence of the government's order that the bodies of all suspected ...

New York hospital tests doctor for Ebola

1 hour ago

A doctor who recently returned to New York from West Africa was rushed to hospital with a fever on Thursday to be tested for possible Ebola, the city's health department said.

User comments